[1]池文婕,靳改玲,王佳敏,等.溃疡性结肠炎患者结肠黏膜组织叉头框转录因子M1、核因子-κΒ mRNA表达与病情严重程度关系研究[J].陕西医学杂志,2024,(9):1264-1268.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.024]
　CHI Wenjie,JIN Gailing,WANG Jiamin,et al.Relationship between expression of FoxM1,NF-κΒ mRNA in colonic mucosal tissue of patients with ulcerative colitis and severity of the disease[J].,2024,(9):1264-1268.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.024]
点击复制

溃疡性结肠炎患者结肠黏膜组织叉头框转录因子M1、核因子-κΒ mRNA表达与病情严重程度关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年9期
页码:
1264-1268
栏目:
临床病理
出版日期:
2024-09-05

文章信息/Info

Title:
Relationship between expression of FoxM1,NF-κΒ mRNA in colonic mucosal tissue of patients with ulcerative colitis and severity of the disease
作者:
池文婕; 靳改玲; 王佳敏; 魏 岚; 王利民
(河北北方学院附属第二医院消化内科,河北 张家口 075100)
Author(s):
CHI Wenjie; JIN Gailing; WANG Jiamin; WEI Lan; WANG Limin
(Department of Gastroenterology,the Second Hospital Affiliated to Hebei North University,Zhangjiakou 075100,China)
关键词:
溃疡性结肠炎;  结肠黏膜组织;  叉头框转录因子M1;  核因子-κΒ;  活动期;  缓解期;  病情严重程度
Keywords:
Ulcerative colitis;  Colonic mucosal tissue;  Forkhead box M1;  Nuclear factor-κΒ;  Active period;  Remission period;  Severity of disease
分类号:
R 574.62
DOI:
DOI:10.3969/j.issn.1000-7377.2024.09.024
文献标志码:
A
摘要:
目的:探究溃疡性结肠炎(UC)患者结肠黏膜组织叉头框转录因子M1(FoxM1)、核因子-κΒ(NF-κΒ)mRNA表达与病情严重程度的关系。方法:选取活动期UC患者128例为活动期UC组、缓解期UC患者81例为缓解期UC组、结肠单发息肉切除术后肠镜复查正常者88例为对照组。以改良Truelove和Witts分型标准将活动期UC患者按病情严重程度分成活动期轻度组(53例)和活动期中度组(46例)和活动期重度组(29例)。荧光定量PCR法检测受试者结肠黏膜组织FoxM1、NF-κΒ mRNA表达。比较对照组、缓解期UC组、活动期UC组和不同病情严重程度活动期UC患者FoxM1 mRNA、NF-κΒ mRNA表达及改良Mayo评分。分析UC患者结肠黏膜组织FoxM1 mRNA、NF-κΒ mRNA、改良Mayo评分的相关性,影响活动期UC患者重度病情发生的因素,FoxM1 mRNA、NF-κΒ mRNA预测活动期UC患者重度病情发生的价值。结果:与对照组和缓解期UC组比较,活动期UC组结肠黏膜组织FoxM1、NF-κΒ mRNA表达水平升高(均P<0.05)。与缓解期UC组比较,活动期UC组改良Mayo评分升高(P<0.05)。活动期轻度组、活动期中度组、活动期重度组结肠黏膜组织FoxM1 mRNA、NF-κΒ mRNA表达水平及改良Mayo评分依次升高(均P<0.05)。UC患者结肠黏膜组织FoxM1 mRNA与NF-κΒ mRNA表达呈正相关(P<0.05)。FoxM1 mRNA、NF-κΒ mRNA与改良Mayo评分呈正相关(均P<0.05)。FoxM1 mRNA、NF-κΒ mRNA、改良Mayo评分是活动期UC患者发生重度病情的危险因素(均P<0.05)。FoxM1、NF-κΒ mRNA两项联合预测活动期UC患者发生重度病情的曲线下面积(AUC)高于FoxM1、NF-κΒ mRNA各自单独预测的AUC(均P<0.05)。结论:FoxM1、NF-κΒ mRNA在活动期UC患者结肠黏膜组织中呈高表达,且病情越重两者升高趋势越明显,可用于预测活动期UC患者重度病情的发生。
Abstract:
Objective:To investigate the relationship between the expression of forkhead box M1(FoxM1),nuclear factor-κΒ(NF-κΒ)messenger RNA(mRNA)in colonic mucosal tissue of patients with ulcerative colitis(UC)and the severity of the disease.Methods:A total of 128 patients with active UC were selected as the active UC group,81 patients with remission UC were selected as the remission UC group,and 88 patients with normal colonoscopy after single colon polypectomy were selected as the control group.According to the improved Truelove and Witts classification criteria,active UC patients were divided into three groups based on the severity of their condition:53 cases in mild active group,46 cases in moderate active group,and 29 cases in severe active group.The mRNA expressions of FoxM1 and NF-κΒ in colonic mucosal tissue were detected by fluorescence quantitative PCR.The expressions of FoxM1,NF-κΒ mRNA and modified Mayo score in control group,remission UC group,active UC group and UC patients with different severity of disease were compared.The correlation of FoxM1,NF-κΒ mRNA and modified Mayo score in colon mucosal tissue of UC patients,the factors affecting the occurrence of severe disease in active UC patients,and the value of FoxM1 and NF-κΒ mRNA in predicting the occurrence of severe disease in active UC patients were analyzed.Results:Compared with control group and remission UC group,the expression levels of FoxM1 and NF-κΒ mRNA in colonic mucosal tissue of active UC group were significantly increased(all P<0.05).Compared with remission UC group,the modified Mayo score in active UC group was significantly increased(P<0.05).The expression levels of FoxM1,NF-κΒ mRNA in colonic mucosal tissue and modified Mayo score of mild active group,moderate active group and severe active group were increased successively(P<0.05).There was a positive correlation between FoxM1 and NF-κΒ mRNA in colonic mucosal tissue of UC patients(P<0.05).FoxM1 and NF-κΒ mRNA were positively correlated with the modified Mayo score(all P<0.05).FoxM1,NF-κΒ mRNA and modified Mayo score were risk factors for severe disease in active UC patients(all P<0.05).The AUC of FoxM1 and NF-κΒ mRNA combined predicted severe disease in active UC patients was higher than that predicted by FoxM1 and NF-κΒ mRNA alone(all P<0.05).Conclusion:FoxM1,NF-κΒ mRNA are highly expressed in the colonic mucosal tissue of active UC patients,and the more severe the condition,the more obvious the increasing trend of both,which can be used to predict the occurrence of severe disease in active UC patients.

参考文献/References:

[1] MA Y,ZHANG X,XUAN B,et al.Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis[J].Gut,2024,73(2):268-281.
[2] 张罡,叶桐,窦丹波.基于NF-κB相关信号通路探讨常用中药治疗溃疡性结肠炎研究进展[J].陕西中医,2023,44(6):818-821.
[3] ZHANG Z,LI M,SUN T,et al.FOXM1:Functional roles of FOXM1 in non-malignant diseases[J].Biomolecules,2023,13(5):857-881.
[4] DAI L,CHEN X,ZHANG H,et al.RND3 transcriptionally regulated by FOXM1 inhibits the migration and inflammation of synovial fibroblasts in rheumatoid arthritis through the Rho/ROCK pathway[J].J Interferon Cytokine Res,2022,42(6):279-289.
[5] 李伟,王旭,房清丽.毛细支气管炎患儿糖皮质激素治疗前后血清白细胞介素-6、肿瘤坏死因子-α、微小RNA-302e、核因子-κB mRNA水平变化及意义[J].陕西医学杂志,2023,52(12):1697-1701.
[6] MOSTAFA R E,ABDEL-RAHMAN R F.Ezetimibe alleviates acetic acid-induced ulcerative colitis in rats:Targeting the Akt/NF-κB/STAT3/CXCL10 signaling axis[J].J Pharm Pharmacol,2023,75(4):533-543.
[7] ZHOU M,SHI J,LAN S,et al.FOXM1 regulates the proliferation,apoptosis and inflammatory response of keratinocytes through the NF-κB signaling pathway[J].Hum Exp Toxicol,2021,40(7):1130-1140.
[8] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年?北京)[J].中国实用内科杂志,2018,38(9):796-813.
[9] MAGRO F,PAI R K,KOBAYASHI T,et al.Resolving histological inflammation in ulcerative colitis with mirikizumab in the LUCENT induction and maintenance trial programmes[J].J Crohns Colitis,2023,17(9):1457-1470.
[10] LU X,JARRETT J,SADLER S,et al.Comparative efficacy of advanced treatments in biologic-naive or biologic-experienced patients with ulcerative colitis:A systematic review and network meta-analysis[J].Int J Clin Pharm,2023,45(2):330-341.
[11] KHALILI H,HAKANSSON N,CASEY K,et al.Diet quality and risk of older-onset Crohn's disease and ulcerative colitis[J].J Crohns Colitis,2023,17(5):746-753.
[12] 张浩冉,崔海栋,梁国英.生物制剂在溃疡性结肠炎治疗中应用的研究进展[J].国际消化病杂志,2023,43(4):213-216.
[13] PANÉS J,COLOMBEL J F,D'HAENS G R,et al.Higher vs standard adalimumab induction and maintenance dosing regimens for treatment of ulcerative colitis:SERENE UC trial results[J].Gastroenterology,2022,162(7):1891-1910.
[14] 耿明胜,李翠娟,成晓萍,等.从脏腑、风寒湿瘀角度探析溃疡性结肠炎[J].陕西中医,2023,44(8):1106-1108.
[15] LUO Y,GE S,CHEN Q,et al.Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome[J].Stem Cell Res Ther,2023,14(1):27-45.
[16] ZHAO J,WANG F,TIAN Q,et al.Involvement of miR-214-3p/FOXM1 axis during the progression of psoriasis[J].Inflammation,2022,45(1):267-278.
[17] 陈娜,赵佳.微小RNA-325-3p和叉头框蛋白M1在胃腺癌中的表达及靶向关系研究[J].陕西医学杂志,2023,52(3):349-353.
[18] YUAN Q,WEN M,XU C,et al.Retraction:8-bromo-7-methoxychrysin targets NF-κB and FoxM1 to inhibit lung cancer stem cells induced by pro-inflammatory factors[J].J Cancer,2022,13(15):3716.
[19] LI X,CHEN F,JU J,et al.Long non-coding RNA-GDA-1 promotes keratinocyte proliferation and psoriasis inflammation by regulating the STAT3/NF-κB signaling pathway via forkhead Box M1[J].Inflammation,2023,46(4):1209-1220.
[20] ZENG R,LU X,LIN J,et al.FOXM1 activates JAK1/STAT3 pathway in human osteoarthritis cartilage cell inflammatory reaction[J].Exp Biol Med(Maywood),2021,246(6):644-653.
[21] ZHOU L,ZHU L,WU X,et al.Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease[J].BMC Med,2023,21(1):287-305.
[22] XU X,ZHANG L,HUA F,et al.FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy[J].Exp Cell Res,2021,408(2):112863.
[23] 张小占,张雯,杨旋.维生素D水平与溃疡性结肠炎患者TLR4/NF-κB信号通路及疾病活动度的相关性分析[J].中国现代医学杂志,2023,33(13):20-26.
[24] PEYRIN-BIROULET L,ALLEGRETTI J R,RUBIN D T,et al.Guselkumab in patients with moderately to severely active ulcerative colitis:QUASAR phase 2b induction study[J].Gastroenterology,2023,165(6):1443-1457.
[25] WEI J,CHEN C,FENG J,et al.Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-κB signaling pathway[J].J Transl Med,2023,21(1):793-807.

相似文献/References:

[1]李竹林,赵 瑛.高强度间歇性运动联合药物治疗溃疡性结肠炎疗效及对患者细胞因子水平影响研究*[J].陕西医学杂志,2019,(7):909.
　LI Zhulin,ZHAO Ying..Therapeutic effect of high-intensity intermittent exercise combined with drugs on ulcerative colitis and its effect on cytokine levels in patients[J].,2019,(9):909.
[2]陈玉林,董甲庆△.复方谷氨酰胺颗粒与肠内营养治疗溃疡性结肠炎临床研究[J].陕西医学杂志,2020,49(1):115.
　CHEN Yulin,DONG Jiaqing..Clinical study of compound glutamine granules and enteral nutrition in the treatment of ulcerative colitis[J].,2020,49(9):115.
[3]安 敏,高振军.美沙拉秦长期治疗对溃疡性结肠炎患者结肠黏膜癌相关基因表达的影响[J].陕西医学杂志,2021,50(4):485.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.027]
[4]付 静,刘小婷,孙 婷,等.陕产七叶一枝花对小鼠溃疡性结肠炎的治疗作用及机制实验研究[J].陕西医学杂志,2024,(9):1161.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.002]
　FU Jing,LIU Xiaoting,SUN Ting,et al.Therapeutic effect and mechanism of Paris polyphylla Sm. from Shaanxi on ulcerative colitis in mice[J].,2024,(9):1161.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.002]
[5]黄小刚,崔锦珠,覃小华,等.基于细胞焦亡探讨龙血竭治疗溃疡性结肠炎机制研究进展[J].陕西医学杂志,2024,(9):1282.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.028]
　HUANG Xiaogang,CUI Jinzhu,QIN Xiaohua,et al.Research progress on mechanism of dragon's blood in treatment of ulcerative colitis based on pyroptosis[J].,2024,(9):1282.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.028]
[6]袁芸菲,刘清娥,李 森,等.桔梗多糖经血小板衍生生长因子受体/血管内皮生长因子受体途径调控巨噬细胞对溃疡性结肠炎模型小鼠黏膜损伤的改善作用及机制研究[J].陕西医学杂志,2025,54(3):301.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.003]
　YUAN Yunfei,LIU Qing'e,LI Sen,et al.Effect and mechanism of platycodon grandiflorum polysaccharides regulating macrophages through PDGF/VEGF receptor pathway in improving mucosal damage in ulcerative colitis model mice[J].,2025,54(9):301.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.003]

备注/Memo

备注/Memo:
基金项目:河北省医学科学研究课题(20220495)
更新日期/Last Update: 2024-09-04